Introduction
Colistin is considered as one of the last-resort treatments against human infections caused by MDR Gram-negative bacteria. 1 Colistin has been used extensively in veterinary medicine for decades, both as a curative treatment and a prophylaxis drug. For veterinary use, colistin is administered with food in pig and poultry farming to prevent infections caused by pathogens. 2 Colistin sulphate has also been used in the seafood industry to promote the growth of fish. 3 The extensive use of colistin in animals may result in high selective pressure in the veterinary environment. 4 The first plasmidmediated colistin resistance gene, mcr-1, was identified on an IncI2 plasmid from Escherichia coli and Klebsiella pneumoniae in China. 4 Recently, the mcr-1 gene has been proven to disseminate ubiquitously, 5 suggesting that the use of colistin has probably accelerated the dissemination of the mcr-1 gene in animals and humans. The use of colistin in both animals and humans has been evaluated and changes in colistin feeding have been implemented. China has banned the use of colistin as a feed additive for animals, which will lead to the withdrawal of .8000 tons of colistin as a growth promoter in veterinary medicine. 6 Furthermore, the EMA updated their advice on the use of colistin in humans and animals in Europe to reduce the use in animals by 65% during the next few years. 7 Recently, plasmid-mediated colistin resistance genes mcr-1 (1626 bp), 4 mcr-2 (1617 bp), 8 mcr-3 (1626 bp), 9 mcr-4 (1626 bp) 10 and mcr-5 (1644 bp) 11 have been identified in various species in humans and animals. Furthermore, mcr-2.2 (1617 bp) 12 has been renamed as mcr-6. Here, we identified a novel mobile phosphoethanolamine transferase gene causing colistin resistance [mcr-7.1 (1620 bp)] in K. pneumoniae strains recovered from chickens in China, which is located on an IncI2-type conjugative plasmid.
Materials and methods

Bacterial strains
In total, 183 non-duplicated K. pneumoniae isolates were collected between 2010 and 2015 from chickens across 13 provinces and municipalities in China (Anhui, Hebei, Heilongjiang, Henan, Hubei, Jiangsu, Liaoning, Ningxia, Shandong, Shanghai, Sichuan, Tianjin and Xinjiang). These isolates were collected from different sample sources: organs (n " 104), digestive tracts (n " 46) and faecal swabs (n " 33). All isolates were identified using an automated system (BD Diagnostic Systems, Sparks, MD, USA). 
Antimicrobial susceptibility testing
All isolates were examined for susceptibility to antimicrobial agents using the disc diffusion method and MIC determination (colistin) following CLSI guidelines. 13 The following antimicrobials (Oxoid, Thermo Fisher Scientific, Basingstoke, UK) were tested: colistin, amikacin, cefotaxime, ceftazidime, gentamicin, neomycin, amoxicillin/clavulanic acid, ciprofloxacin, levofloxacin, norfloxacin, nalidixic acid, sulfamethoxazole/trimethoprim, streptomycin, aztreonam, doxycycline, imipenem, cefoxitin and florfenicol. MICs of antimicrobials for the colistin-resistant isolates were determined using broth microdilution following CLSI guidelines. 13 The results were interpreted according to CLSI instructions, 13 and colistin resistance was defined according to EUCAST clinical breakpoints (epidemiological cut-off values; http://www.eucast.org/).
PCR amplification and sequencing
Genomic DNA of all K. pneumoniae isolates was extracted using a QIAamp DNA Mini Kit following the manufacturer's recommendations (QIAGEN, Hilden, Germany). The mcr-1 gene 4 was screened for in all K. pneumoniae isolates by PCR amplification. For the colistin-resistant isolates that were negative for mcr-1, further screening of all known plasmid-mediated colistin resistance genes (mcr-2, 8 mcr-3, 9 mcr-4 10 and mcr- 5 11 ) was carried out by PCR. All the primers are listed in Table S1 (available as Supplementary data at JAC Online) and PCR conditions were selected as previously described. PCR screening of mcr-7.1 was performed on colistin-resistant K. pneumoniae isolates. PCR conditions were 3 min at 94 C followed by 30 cycles at 94 C for 30 s, 55 C for 30 s and 72 C for 30 s, and a final extension at 72 C for 10 min. Sanger sequencing was performed using a DNA analyser (Applied Biosystems, Life Technologies) and analysed online using BLAST (http://blast.ncbi.nlm.nih.gov/Blast.cgi).
WGS
WGS was performed using an Illumina HiSeq 2000 system with a genome coverage .300%. Raw reads were assembled using SPAdes version 3.10.
14 Plasmid assembly was performed using plasmidSPAdes 15 and confirmed by a PCR-based closure, using the primers listed in Table S1 . Assembly of shufflon segments was checked in genomic assemblies and plasmidspecific assemblies. Furthermore, shufflon sequences in IncI2-type plasmid R721 (GenBank accession no. X62169) were extracted as reference sequences 16 to conduct a manual comparison with raw reads of WGS. We further used BLASTn to compare shufflon segments in pSC20141012 with publicly available IncI2-type plasmids. As a result, the complete plasmid, including the shufflon, was assembled as a single contig. The sequences were analysed with DNASTAR Lasergene (DNASTAR, Madison, WI, USA) and BLAST. MLST for K. pneumoniae SC20141012 was conducted as previously described. 17 Plasmid replicon types were detected using PlasmidFinder version 1.3. 18 Coding sequences were predicted using Prodigal (version 2.6) 19 and annotated using the rapid prokaryotic genome annotation tool Prokka. 20 The resistance genes were identified by submitting the complete sequence to the Center for Genomic Epidemiology (https://cge.cbs.dtu.dk/ services/ResFinder/). IS elements were confirmed by searching in ISFinder (https://isfinder.biotoul.fr). The integrated IS elements for the whole plasmid were annotated using ISsaga (http://issaga.biotoul.fr). The complete sequence with annotation of pSC20141012 was submitted to the National Center for Biotechnology Information (NCBI) database and assigned the accession number MG267386.
Conjugation experiments
The transferability of plasmids was investigated by conducting conjugation experiments. 21 Isolates conferring resistance to colistin served as donors and E. coli J53Az r served as the recipient. Transconjugants were selected on Mueller-Hinton agar plates containing colistin (2 mg/L) and sodium azide (150 mg/L). The mcr-7.1-positive transconjugants were confirmed by antimicrobial susceptibility testing and Sanger sequencing.
Gene cloning and protein expression
The genomic DNA of K. pneumoniae SC20141012 was extracted using a QIAamp DNA Mini Kit. The mcr-7.1 gene was amplified using high-fidelity PrimeSTAR Max DNA Polymerase (Takara, Shiga, Japan). The PCR product was digested with EcoRI and XhoI and ligated into the expression vector pET28a, which was digested with the same enzymes. The expression of recombinant MCR-7.1 in E. coli BL21 was induced by adding IPTG when the OD at 600 nm (OD 600 ) of cells reached 0.6. SDS-PAGE was performed to confirm the expression of mcr-7.1.
Protein sequence alignment and structure prediction
Conserved domains of MCR-7.1 and MCR-3 were predicted using the CD-Search 22 tool in NCBI against the Pfam database. The structure of MCR-7.1 and MCR-3 was predicted using RaptorX. 23 To construct a maximumlikelihood phylogeny of MCR-7.1 and MCR-related proteins, multiple sequence alignment was performed using MUSCLE. 24 We then used RAxML 25 to calculate the phylogenetic tree from the combined alignment file with 100 bootstraps.
Results and discussion
Screening for colistin-resistant isolates
In total, 183 non-duplicated K. pneumoniae isolates were collected between 2010 and 2015 from chickens in 13 provinces in China. Of those, 10 were colistin-resistant isolates with the MIC of colistin ranging from 4 to 32 mg/L. mcr-1 was detected in seven of the colistin-resistant isolates. Notably, three isolates had an MIC of 4 mg/L for colistin (Table S2) ; however, these were negative for known plasmid-mediated colistin resistance genes. One isolate (MIC " 4 mg/L) named SC20141012, obtained from the intestinal tract of a chicken in Sichuan province in 2014, was selected for WGS. SC20141012 is an ST15 isolate carrying: chromosomally encoded resistance genes bla SHV-28 (b-lactam resistance), oqxAB (quinolone resistance) and fosA (fosfomycin resistance); and plasmid-mediated resistance genes bla CTX-M-55 (b-lactam resistance) and aph(3 0 )-Ia (aminoglycoside resistance).
Identification of a novel colistin resistance gene in K. pneumoniae
The complete sequence of pSC20141012 (GenBank accession no. MG267386) is 65 631 bp in size and contains 87 predicted ORFs ( Figure 1 and Figure S1 ). BLASTn comparison showed that an ORF, assigned as a putative phosphoethanolamine transferase gene in this plasmid, exhibited 78% nucleotide identity to part of the mcr-3 gene. The capability of this ORF to cause colistin resistance was proven by conjugation experiments. The plasmid can be successfully transferred from K. pneumoniae SC20141012 to E. coli J53Az r with a frequency of 4 % 10 #4 per recipient cell. MIC testing revealed MIC values of 4 mg/L for transconjugants, exhibiting a 8-fold increase compared with the recipient E. coli J53Az r (Table S2 ). This 1620 bp predicted ORF, encoding a protein annotated as a phosphoethanolamine transferase, was named mcr-7.1. PCR screening of mcr-7.1 revealed that two other K. pneumoniae isolates that were negative for known colistin Yang et al.
resistance genes also carried mcr-7.1. The mcr-7.1 gene was not found in mcr-1-positive K. pneumoniae isolates.
Furthermore, we investigated the expression of mcr-7.1 using an expression vector. Results of SDS-PAGE showed that MCR-7.1 was expressed and induced by IPTG and had an approximate molecular mass of 60 kDa ( Figure S2 ). The recombinant plasmid carrying mcr-7.1 in E. coli BL21 (DE3), which conferred a colistin MIC of 4 mg/L, exhibited an 8-fold increase compared with the empty vector (0.5 mg/L).
Genetic context of mcr-7.1 on IncI2-type plasmid
The mcr-7.1-carrying pSC20141012 was analysed to explore the genetic background of mcr-7.1. There was no mobile element found in the flanking regions of mcr-7.1 on pSC20141012 (Figure 1 ). It is possible that mcr-7.1 was immobilized on the plasmid following the loss of the flanking IS elements. The studies on mcr-1 gave an example that mcr-1 was stabilized on the plasmid following the formation of ISApl1 composite transposon, transposition and loss of ISApl1 elements (Figure 1) . 26, 27 The genetic context of mcr-7.1 on plasmids needs to be further investigated with more mcr-7.1-positive isolates identified. Notably, a BLASTn search revealed that a 3264 bp mcr-7.1-carrying region downstream of nikB in pSC20141012 does not match the usual IncI2 backbone and that part of it (2000 bp, 77% identity) matches Aeromonas. Insertion of the mcr-7.1-carrying region did not cause deletion of plasmid backbone sequences. Within this region, a 381 bp ORF (the dgkA gene) downstream of mcr-7.1 exhibits 82% nucleotide identity to Aeromonas. The diacylglycerol kinase-coding dgkA gene, involved in the phosphatidic acid pathway, was also found downstream of mcr-3 in pWJ1 (GenBank accession no. KY924928.1). 9 Furthermore, the ORF upstream of mcr-7.1 exhibits 81% identity to a putative phosphodiesterase gene in Aeromonas.
In addition to mcr-7.1, the bla CTX-M-55 gene, located in a typical ISEcp1-bla CTX-M-15 transposition unit, was also found in pSC20141012. This transposition unit is inserted downstream of Novel colistin resistance gene mcr-7.1 JAC the yajA gene in the opposite orientation and is flanked by 5 bp DRs (GAAAA) characteristic of ISEcp1 transposition, which was identical to the genetic environment in pSTH21 (Figure 1) . 28 We then compared our plasmid with reference plasmids with high sequence similarity (Figure 1 ). They were all IncI2-type plasmids that harboured mcr and/or bla CTX-M-55 genes. They all possessed a typical IncI2-type plasmid backbone scaffold, including a replicon gene (repA) and genes involved in plasmid stability (stbDE genes), the formation of type IV pilus (pil gene cluster) and conjugative transfer (vir gene cluster). The mcr gene was found downstream of the nikB gene in all plasmids selected.
Sequence alignment and origin of MCR-7.1
The deduced amino acid sequence of the mcr-7.1 gene product, MCR-7.1, has 539 amino acids and was annotated as a phosphoethanolamine transferase. The MCR-7.1 protein sequence was aligned to MCR-1, MCR-2, MCR-3, MCR-4, MCR-5 and MCR-6. MCR-7.1 is distinct from MCR-1, MCR-2, MCR-3, MCR-4, MCR-5 and MCR-6, with amino acid identities of 35%, 34%, 70%, 45%, 36% and 33%, respectively. The structure of MCR-7.1 can be divided into two domains: a domain predicted to be a phosphoethanolamine transferase (sulphatase) (amino acids 231-516, Pfam no. PF00884) and a domain predicted to be a transmembrane module (amino acids 54-202, Pfam no. PF08019), which demonstrated a similar structure to that of MCR-3 (Figure 2a) .
A BLASTp search of MCR-7.1 identified hits to phosphoethanolamine transferase from Aeromonas sp. (69%-81% identity), Citrobacter freundii (GenBank accession no. WP_087879616.1, 99% query coverage and 70% identity), K. pneumoniae (GenBank accession no. WP_065801616.1, 99% query coverage and 70% identity) and Shigella sonnei (GenBank accession no. WP_094321595.1, 99% query coverage and 70% identity). They are all annotated as MCR-3 family phosphoethanolamine transferases. Phylogenetic analysis revealed that MCR-7.1 shares close genetic distance to MCR-3 and MCR-3-like sequences (Figure 2b) . Notably, almost all the MCR-3-like sequences close to MCR-7.1 are derived from Aeromonas species. Furthermore, an ORF upstream of mcr-7.1 in pSC20141012 was found close to a putative phosphodiesterase gene in Aeromonas veronii. These findings suggest that, just like MCR-3, 9 MCR-7.1 originated from Aeromonas species.
Conclusions
Our findings demonstrate the presence of a new plasmid-mediated colistin resistance gene mcr-7.1 in K. pneumoniae in China. An IncI2-type conjugative plasmid co-harbouring the mcr-7.1 and bla CTX-M-55 genes was identified. The amino acid sequence of MCR-7.1 shares 70% similarity to MCR-3, suggesting MCR-7.1 may have originated from Aeromonas species. Screening for the mcr-7.1 gene in other species in animals, the environment and humans is necessary to understand its dissemination throughout the world. 
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